AstraZeneca (AZNL)

10,056.00p
   
  • Change Today:
      0.57p
  • 52 Week High: 13,250.00p
  • 52 Week Low: 9,521.00p
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 395,621
  • Market Cap: £127,124m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Sep-24 Interim 13,565.00 1,828.00 92.00¢ n/a

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 24,384.00 1,548.00 103.00¢ 93.0 n/a -39% 280.00¢ 2.9%
31-Dec-20 26,617.00 3,916.00 244.00¢ 37.9 0.3 +137% 280.00¢ 3.0%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,362.6 n/a -97% 287.00¢ 2.6%
31-Dec-22 44,351.00 2,501.00 212.00¢ 66.8 0.0 +2,550% 290.00¢ 2.0%
31-Dec-23 45,811.00 6,899.00 384.00¢ 34.7 0.4 +81% 290.00¢ 2.2%

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 52,506.01 15,651.61 630.61p 15.9 0.1 +108% 247.02p 0.0%
31-Dec-25 56,662.22 17,747.05 725.34p 13.9 0.9 +15% 259.29p 0.0%
31-Dec-26 59,880.19 19,902.57 824.30p 12.2 0.9 +14% 272.59p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 43.94 41.10 342.02 0.10

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,056.00p
Change Today 0.57p
% Change 0.57 %
52 Week High 13,250.00p
52 Week Low 9,521.00p
Volume 395,621
Shares Issued 1,264.16m
Market Cap £127,124m

What The Brokers Say

Strong Buy 9
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 21-Nov-2024

Time Volume / Share Price
16:29 24 @ 10,056.00p
16:29 92 @ 10,056.00p
16:29 1 @ 10,056.00p
16:29 5 @ 10,056.00p
16:29 20 @ 10,054.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page